C.s possible case against Google, but whatever concessions the company might make, either to avoid a trial or in response to its outcome, should have to deal not only with the present playing field, but also with how it does or does not expand into adjacent lines of business.
According to the companies, the FDA sent a complete response letter regarding the trial-stage drug Horizant, which is in the form of an extended-release pill taken to lessen pain caused by the condition.